Ultragenyx Pharmaceutical(DE:UP0)
€14.58-0.36 (-2.38%)
DE:UP0
Ultragenyx Pharmaceutical earnings date
€14.58
At close:-0.36 (-2.38%)
Ultragenyx Pharmaceutical (UP0) Q2 2019 Earnings Report
2 Followers
DE:UP0 Q2 2019 EPS Results
- Actual EPS
- -EUR 1.55
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.96
DE:UP0 Q2 2019 Revenue Results
- Actual Revenue
- EUR 21.83M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +88.75%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/01/2019
- Time
- After Close
- Conference Call
- Thursday, August 1, 2019
DE:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.16- | -1.17 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.99-1.05 | -1.64 | 35.91% (+0.59) | |
| Aug 04, 2026 | 2026 (Q2) | -1.12-0.81 | -1.06 | 23.08% (+0.24) | |
| May 05, 2026 | 2026 (Q1) | -1.35-1.66 | -1.42 | -17.20% (-0.24) | |
| Feb 12, 2026 | 2025 (Q4) | -0.99-1.17 | -1.26 | 7.19% (+0.09) | |
| Nov 04, 2025 | 2025 (Q3) | -1.12-1.64 | -1.27 | -29.29% (-0.37) | |
| Aug 05, 2025 | 2025 (Q2) | -1.17-1.06 | -1.37 | 23.03% (+0.32) | |
| May 06, 2025 | 2025 (Q1) | -1.44-1.42 | -1.83 | 22.66% (+0.42) | |
| Feb 13, 2025 | 2024 (Q4) | -1.18-1.26 | -1.37 | 8.55% (+0.12) | |
| Nov 05, 2024 | 2024 (Q3) | -1.34-1.27 | -2.02 | 37.22% (+0.75) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
